249 related articles for article (PubMed ID: 25510432)
1. Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemia.
Qiu JJ; Zeisig BB; Li S; Liu W; Chu H; Song Y; Giordano A; Schwaller J; Gronemeyer H; Dong S; So CW
Leukemia; 2015 May; 29(5):1153-62. PubMed ID: 25510432
[TBL] [Abstract][Full Text] [Related]
2. Acute Myeloid Leukemia with
Tao S; Song L; Deng Y; Chen Y; Shi Y; Gan Y; Deng Z; Ding B; He Z; Wang C; Yu L
Onco Targets Ther; 2020; 13():10559-10566. PubMed ID: 33116634
[TBL] [Abstract][Full Text] [Related]
3. Leukemic transformation by the APL fusion protein PRKAR1A-RAR{alpha} critically depends on recruitment of RXR{alpha}.
Qiu JJ; Lu X; Zeisig BB; Ma Z; Cai X; Chen S; Gronemeyer H; Tweardy DJ; So CW; Dong S
Blood; 2010 Jan; 115(3):643-52. PubMed ID: 19965660
[TBL] [Abstract][Full Text] [Related]
4. Alkaloid-based regimen is beneficial for acute myeloid leukemia resembling acute promyelocytic leukemia with NUP98/RARG fusion and RUNX1 mutation: A case report.
Wei W; Liu Q; Song F; Cao H; Liu M; Jiang Y; Li Y; Gao S
Medicine (Baltimore); 2020 Oct; 99(40):e22488. PubMed ID: 33019444
[TBL] [Abstract][Full Text] [Related]
5. A novel NPM1-RARG-NPM1 chimeric fusion in acute myeloid leukaemia resembling acute promyelocytic leukaemia but resistant to all-trans retinoic acid and arsenic trioxide.
Chen X; Wang F; Zhang Y; Teng W; Cao P; Ma X; Liu M; Tian Y; Wang T; Nie D; Zhang J; Liu H; Wang W
Br J Cancer; 2019 May; 120(11):1023-1025. PubMed ID: 30996344
[TBL] [Abstract][Full Text] [Related]
6. Candidate genes for expansion and transformation of hematopoietic stem cells by NUP98-HOX fusion genes.
Palmqvist L; Pineault N; Wasslavik C; Humphries RK
PLoS One; 2007 Aug; 2(8):e768. PubMed ID: 17712416
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia with NUP98::RARG resembling acute promyelocytic leukemia accompanying ARID1B gene mutation.
Wu D; Gao R
Hematology; 2023 Dec; 28(1):2227495. PubMed ID: 37387408
[TBL] [Abstract][Full Text] [Related]
8. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
Kizaki M; Dawson MI; Heyman R; Elster E; Morosetti R; Pakkala S; Chen DL; Ueno H; Chao W; Morikawa M; Ikeda Y; Heber D; Pfahl M; Koeffler HP
Blood; 1996 Mar; 87(5):1977-84. PubMed ID: 8634447
[TBL] [Abstract][Full Text] [Related]
9. Report of PRPF19 as a novel partner of RARG and the recurrence of interposition-type fusion in variant acute promyelocytic leukemia.
Wu H; Li H; Zhou X; Zhao Z; Cao P; Li L; Ma X; Yuan L; Wang F; Zhang Y; Chen J; Fang J; Liu M; Liu M; Chen X; Liu H
Hematol Oncol; 2023 Oct; 41(4):784-788. PubMed ID: 37132198
[TBL] [Abstract][Full Text] [Related]
10. [RXR, a key member of the oncogenic complex in acute promyelocytic leukemia].
Halftermeyer J; Le Bras M; De Thé H
Med Sci (Paris); 2011 Nov; 27(11):973-8. PubMed ID: 22130024
[TBL] [Abstract][Full Text] [Related]
11. A novel NUP98-JADE2 fusion in a patient with acute myeloid leukemia resembling acute promyelocytic leukemia.
Cheng CK; Chan HY; Yung YL; Wan TSK; Leung AWK; Li CK; Tian K; Chan NPH; Cheung JS; Ng MHL
Blood Adv; 2022 Jan; 6(2):410-415. PubMed ID: 34673934
[TBL] [Abstract][Full Text] [Related]
12. A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia.
Such E; Cervera J; Valencia A; Barragán E; Ibañez M; Luna I; Fuster O; Perez-Sirvent ML; Senent L; Sempere A; Martinez J; Martín-Aragonés G; Sanz MA
Blood; 2011 Jan; 117(1):242-5. PubMed ID: 20935257
[TBL] [Abstract][Full Text] [Related]
13. Nup98-homeodomain fusions interact with endogenous Nup98 during interphase and localize to kinetochores and chromosome arms during mitosis.
Xu S; Powers MA
Mol Biol Cell; 2010 May; 21(9):1585-96. PubMed ID: 20237156
[TBL] [Abstract][Full Text] [Related]
14. A short report of novel
Song Y; Hou J; Wan L; Liu K; Zhou C; Wei S; Zhang G; Lin D; Li Y; Fang Q; Liu Y; Gong B; Gong X; Wang Y; Wei H; Wang J; Mi Y
Hematology; 2022 Dec; 27(1):518-522. PubMed ID: 35544458
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins.
Takeda A; Sarma NJ; Abdul-Nabi AM; Yaseen NR
J Biol Chem; 2010 May; 285(21):16248-57. PubMed ID: 20233715
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of the NUP98-CCDC28A fusion protein.
Petit A; Ragu C; Soler G; Ottolenghi C; Schluth C; Radford-Weiss I; Schneider-Maunoury S; Callebaut I; Dastugue N; Drabkin HA; Bernard OA; Romana S; Penard-Lacronique V
Haematologica; 2012 Mar; 97(3):379-87. PubMed ID: 22058212
[TBL] [Abstract][Full Text] [Related]
17. Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor.
Hirose K; Abramovich C; Argiropoulos B; Humphries RK
Oncogene; 2008 Oct; 27(46):6056-67. PubMed ID: 18604245
[TBL] [Abstract][Full Text] [Related]
18. Biomolecular condensation of NUP98 fusion proteins drives leukemogenic gene expression.
Terlecki-Zaniewicz S; Humer T; Eder T; Schmoellerl J; Heyes E; Manhart G; Kuchynka N; Parapatics K; Liberante FG; Müller AC; Tomazou EM; Grebien F
Nat Struct Mol Biol; 2021 Feb; 28(2):190-201. PubMed ID: 33479542
[TBL] [Abstract][Full Text] [Related]
19. Endogenous retinoic acid receptor (RAR)-retinoid X receptor (RXR) heterodimers are the major functional forms regulating retinoid-responsive elements in adult human keratinocytes. Binding of ligands to RAR only is sufficient for RAR-RXR heterodimers to confer ligand-dependent activation of hRAR beta 2/RARE (DR5).
Xiao JH; Durand B; Chambon P; Voorhees JJ
J Biol Chem; 1995 Feb; 270(7):3001-11. PubMed ID: 7852380
[TBL] [Abstract][Full Text] [Related]
20. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.
Dong S; Tweardy DJ
Blood; 2002 Apr; 99(8):2637-46. PubMed ID: 11929748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
